This year’s Life Science Washington Innovation Northwest conference brought hundreds of researchers and entrepreneurs together over two days to discuss a wide range of science and biotech topics.
Among the many events, co-founders of Seattle-based company, Sana Therapeutics, Steve Harr and Hans Bishop, discussed the company going public last year with the largest IPO ever for a preclinical biotech company.
Life Science Washington’s CEO Marc Cummings also spoke to GeekWire on stage about strengthening the industry, bolstering its workforce and priorities in store for the trade organization.